The future of extracorporeal support

Area of Science:

• Critical Care Medicine
• Biomedical Engineering
• Nephrology

Background:

• Extracorporeal therapy has evolved from solely renal replacement to multi-organ support.
• Multiple organ dysfunction syndrome necessitates advanced extracorporeal interventions.
• Technological progress enables multifaceted blood treatment for organ support.

Purpose of the Study:

• To provide an overview of current and future directions in extracorporeal support.
• To highlight advancements in blood purification technologies for critical care.
• To discuss the integration of nanotechnology and cellular functions in extracorporeal devices.

Main Methods:

• Review of expanded indications for hemofiltration and adsorption therapies.
• Exploration of novel device development using nanotechnology and miniaturization.
• Discussion of incorporating viable cells into extracorporeal devices for synthetic functions.

Main Results:

• Combination therapies enhance blood detoxification capabilities.
• Nanotechnology refines membrane characteristics and monitoring devices.
• Miniaturization leads to wearable/implantable devices.
• Cell-integrated devices offer detoxification and synthetic functions.

Conclusions:

• Extracorporeal support is expanding to encompass multiple organ functions.
• Future extracorporeal devices aim for complete organ function replacement.
• Innovations in nanotechnology and cell integration are key to future advancements.